A kind of medicine for treating hair loss and preparation method thereof

Abstract

The invention discloses a drug for treating alopecia. The drug comprises the following raw materials, by weight part, 1050-3150 parts of Chinese angelica, 410-1230 parts of rhizoma et radix notopterygii, 410-1230 parts of rhizoma ligustici chuanxiong, 2050-6135 parts of prepared rehmannia roots, 1050-3150 parts of dodder seeds, 615-1845 parts of papayas, 2045-6135 parts of prepared fleeceflower roots, 205-615 parts of tall gastrodia tubers and 1050-3150 parts of debark peony roots. The invention further discloses a preparation method of the drug. The drug prepared through the method is high in extraction efficiency of effective components, has the effective components not prone to be damaged, is less in administration amount, and stable in quality.

Description

technical field [0001] The invention relates to the technical field of medicine preparation technology, in particular to a medicine for treating alopecia and a preparation method thereof. Background technique [0002] Hair loss is a common skin disease. Western medicine believes that it is mainly caused by androgen, excessive oil secretion and other reasons. Traditional medicine believes that "the kidney stores the essence, and its flower is in the hair. When the kidney qi is weak, the hair falls off, and the hair turns gray early", and "the hair is the rest of the blood." "The liver stores blood", and the same source of essence and blood transforms each other. Therefore, the quality of hair growth is directly related to the liver, kidney, and qi and blood. Most hair loss patients have deficiency of both liver and kidney, and qi and blood deficiency. Yangxue Shengfa Capsule is a pure traditional Chinese medicine preparation for treating hair loss. It follows the principle o...

AI Technical Summary

Problems solved by technology

At present, the preparation process of the products recorded in the "Chinese Pharmacopoeia" is relatively traditional and simple, and some medicinal materials are directly used as powder without extraction. Not only are there many ineffective or even harmful ingredients such as impurities and heavy metals, but the extraction efficiency of active ingredients is not high, and 4 No. 0 capsules (specification: 0.5g per capsule) are required to be taken each time. The dosage is large, and many patients feel inconvenient to take it.

In addition, traditional wet granulation and steam box drying methods are used in the preparation process, and the prepared granules are easy to stick and agglomerate during the drying process, which requires continuous granulation, high labor intensity, and the heat conduction speed of the steam drying method It is very slow, the drying efficiency is low, and the material is heated unevenly, which will cause a temperature difference between the inside and outside of the heated material, which will affect the quality stability of the product. For example, the main active ingredient stilbene glycosides in Polygonum multiflorum will be destroyed by high temperature heating

Images